Abstract
Over the past decade, artificial intelligence (AI) has significantly reshaped formulation development, drug discovery, and delivery processes. This study examines how AI and its technologies are enhancing efficiency and precision in pharmaceutical research. Crafting novel medications is crucial in the journey of drug development, offering the potential for enhanced bioavailability and targeted distribution. The conventional trial-and-error approach to formulation development, however, demands extensive resources and time-consuming in vitro and in vivo experiments. This article outlines the role of machine learning workflows in optimizing medication formulation processes, with a focus on structure-based and ligand-based drug design. Nanotechnology's potential for revolutionizing healthcare, including drug delivery and microscopic interventions, hinges on data science. Moreover, the exciting prospect of AI-powered nanobots holds promise for targeted drug delivery and tumor treatment with minimal patient impact.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call